Insider Trading Arrangements |
3 Months Ended |
|---|---|
|
Jun. 30, 2025
shares
| |
| Trading Arrangements, by Individual | |
| Non-Rule 10b5-1 Arrangement Adopted | false |
| Rule 10b5-1 Arrangement Terminated | false |
| Non-Rule 10b5-1 Arrangement Terminated | false |
| Dr. Martine Rothblatt [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On May 2, 2025, Dr. Martine Rothblatt, our Chairperson and Chief Executive Officer, adopted a trading plan intended to satisfy Rule 10b5-1(c) to exercise up to 294,000 stock options and sell the shares of our common stock received, subject to certain conditions. These stock options expire in March 2026.
|
| Name | Dr. Martine Rothblatt |
| Title | Chairperson and Chief Executive Officer |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | On May 2, 2025 |
| Expiration Date | March 2026 |
| Arrangement Duration | 333 days |
| Aggregate Available | 294,000 |
| Michael Benkowitz [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On June 3, 2025, trusts beneficially owned by Michael Benkowitz, a Section 16 officer, adopted a trading plan intended to satisfy Rule 10b5-1(c) to exercise up to 576,940 stock options and sell the shares of common stock received, subject to certain conditions. These stock options expire in March 2027.
|
| Name | Michael Benkowitz |
| Title | Section 16 officer |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | On June 3, 2025 |
| Expiration Date | March 2027 |
| Arrangement Duration | 301 days |
| Aggregate Available | 576,940 |